ArticleScientific reports2019

Polymorphisms in MDM2 and TP53 Genes and Risk of Developing Therapy-Related Myeloid Neoplasms.

Maria Cabezas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.